Pharmaceutical Firm Starts to Expand; MEDICINES: After Difficult Year Wrexham Company Is Growing Again Thanks to New Contracts

Western Mail (Cardiff, Wales), October 10, 2001 | Go to article overview
Save to active project

Pharmaceutical Firm Starts to Expand; MEDICINES: After Difficult Year Wrexham Company Is Growing Again Thanks to New Contracts


Byline: WILL SMALE Assistant Business Editor

AFTER a difficult 12 months of reduced profits and redundancies, CP Pharmaceuticals is now taking on extra staff to meet a big upturn in sales.

The Wrexham-based company, like everyone else in the pharmaceutical industry, was hit by the sharp fall in medicine prices over the past year.

Caused by oversupply across the sector, CP's sales dropped by 6pc to pounds 30.4m and operating profit fell severely by 42pc to pounds 2.1m, in the year ending June 30, 2001.

Reacting to the difficult market conditions, the firm recently restructured its business and carried out some redundancies.

Following this strengthening work, and with medicine prices now increasing, CP's directors are confident of a much better year ahead.

A number of multi-million pound orders have just been received and the 430-strong company is currently interviewing for an extra 25 staff at its Wrexham Industrial Estate site.

Andrew Coveney, CP's finance director, said, "We are looking to grow quite strongly this year and have started production on a number of new contracts. In fact, we need to achieve a quite big increase in production.

"We are taking on new employees as we speak, actively recruiting in the region of 25.

And new contracts have been achieved in both the UK and overseas markets, including a major contract with a hi-tech Californian firm, and a pounds 1m deal with a UK and Denmark-based company.

"We are looking to build on these.

"The medicine market is a lot more healthy now. It still hasn't recovered to the levels of a couple of years ago, but it is a lot more stable.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Pharmaceutical Firm Starts to Expand; MEDICINES: After Difficult Year Wrexham Company Is Growing Again Thanks to New Contracts
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?